Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
C-TIL051 + Anti-PD1 Therapy for Lung Cancer
Recruiting1 awardPhase 1
Pittsburgh, Pennsylvania
This trial tests C-TIL051 with anti-PD1 therapy for people with refractory non-small cell lung cancer. It assesses safety & ability to tolerate treatment, & response of the cancer. Participants provide a tumor sample & receive chemo & C-TIL051 & anti-PD1.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service